BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Influenza
,
Kidney
,
Amniocentesis
,
Lipitor
,
rs7903146
,
MDM2
,
Metabolism of xenobiotics
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PHA 4
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Foxa2, a novel protein partner of the tumour suppressor menin, is deregulated in mouse and human MEN…
Integrated chromatin immunoprecipitation sequencing and microarray analysis identifies FOXA2 target …
Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease.
Insm1 cooperates with Neurod1 and Foxa2 to maintain mature pancreatic β-cell function.
SIRT1 mediates FOXA2 breakdown by deacetylation in a nutrient-dependent manner.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study To Evaluate The Dose Response And Safety Of PHA-794428 In Adults With Growth Hormone Deficie…
Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma
A Single Dose Study to Evaluate the PK-PD Response and Safety of PHA-794428 in Children With Growth …
Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines…
Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With He…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ